Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Galt Pharmaceuticals
Galt Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Doral
Quazepam
1985-12-27
2028
Sleep initiation and maintenance disorders
Oravig
Miconazole
2010-04-16
2028
Mycoses
,
Aspergillosis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Tinea versicolor
,
Cutaneous candidiasis
Orphengesic
Aspirin
,
Caffeine
,
Orphenadrine
1998-05-29
2023-2033
Rheumatoid arthritis
,
Pain
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Fatigue
,
Apnea
,
Rheumatic fever
,
Gout
,
Myositis
,
Muscle cramp
,
Spasm
,
Tetanus
,
Muscle rigidity
,
Muscle spasticity
,
Cough
,
Anxiety disorders
,
Gastroesophageal reflux
,
Helicobacter infections
,
Stomach ulcer
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Postoperative pain
,
Hypercholesterolemia
,
Coronary artery disease
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Obstructive lung diseases
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use